Overview

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Azilsartan medoxomil
Olmesartan
Olmesartan Medoxomil